Home› The Breastcancer.org Community Forum› Living with metastatic disease› Stage IV/Metastatic Breast Cancer ONLY
We need your mantras for a new project! Share with us.

Testing for ESR1 Mutations, Then Switching to Camizestrant Improves Outcomes for HR+ HER2- MBC

moderators
moderators Posts: 10,261
June 2025 in Stage IV/Metastatic Breast Cancer ONLY

Testing for ESR1 Mutations, Then Switching to Camizestrant Improves Outcomes for Metastatic HR+ HER2- Breast Cancer

May 31, 2025

After two years of follow-up, the new treatment improved survival and quality of life. Read more…

Tagged:
  • Metastatic Breast Cancer (MBC or Stage IV)
  • ER-positive
  • HER2-negative
  • Hormone receptor-positive HER2-negative
  • PR-positive
  • ESR1
  • Research News
0

Categories

  • All Categories
  • 1.5K Concerned about my risk
  • 1.8K Connect with others like me
  • 2.1K In treatment
  • 612 Managing life with cancer
  • 165 Finished treatment
  • 851 Living with metastatic disease
  • 55 Caring for someone
  • 255 Tributes
  • 73 Discussion forum resources
Join Us on Zoom: Upcoming virtual support groups. Read more...
Share more about you! Fill out your profile.